Home
The Firm
About Us
Thera Team
Our Expertise
Our Services
What We Deliver
Projects
Topics
Disease-related
Asthma
Cancer
Cardiovascular-Reno-Metabolic
COPD
Migraine
Mental Health
Obesity
Rare diseases
Schizophrenia
Women’s health
Structural
Artificial Intelligence and Its Impact on Health
Biosimilars
Complex Generics
Digital Health
Evidence-based Health Policies
Patient Participation
Pharmaceutical Relocation
Regulatory Convergence & Harmonization
Unfair Competition
Value in Health
Documents
Policy papers
Columns
Artificial Intelligence and Its Impact on Health – El Economista
Biosimilars LATAM – El Economista
Cardio-Reno-Metabolic Axis – El Economista
Complex Generics – El Economista
COPD set to become the third leading cause of death – El Economista
Digital Health – El Economista
Health Policies without Evidence – El Economista
Mental Health OECD 2025 – El Economista
Migraine – El Economista
Obesity – El Economista
Patient Paticipation in Health Decision-Making – El Economista
Pharmaceutical Relocation – El Economista
Regulatory Convergence & Harmonization – El Economista
Schizophrenia: the cost of silence and the value of action – El Economista
Unfair Competition – El Economista
Value in Health – El Economista
Women’s Health Gaps – El Economista
World Asthma Day – El Economista
Word Cancer Day 2026 – El Economista
World Rare Disease Day 2026 – El Economista
News
Health Policy & Systems
ALIFAR 2026
Column on Cardio-Reno-Metabolic Syndrome – El Economista, June 10th, 2026
Market Access
Column Biosimilars LATAM – El Economista, April 10th, 2026
Column Unfair Competition – El Economista, April 30th, 2026
Legal & Regulatory
Multi-Stakeholders Collaboration
Ethics & Compliance
